Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$68.12 USD

68.12
5,481,354

+1.62 (2.44%)

Updated Aug 15, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

What's in Store for Edwards Lifesciences (EW) in Q1 Earnings?

Continued strength in the adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q1 revenues.

Mark Vickery headshot

Top Analyst Reports for Facebook, Adobe & Novo Nordisk

Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Adobe (ADBE), and Novo Nordisk (NVO).

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

Leader in treating stroke with catheter-based technology has fully recovered from a product recall

Sheraz Mian headshot

Q4 Earnings Season Scorecard and Research Reports for Toyota, PepsiCo & BlackRock

We have provided a real-time update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks in today's Research Daily.

Edwards Lifesciences (EW) Q4 Earnings Fall Shy of Estimates

Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust performances in TMTT business in Q4.

Edwards Lifesciences (EW) Q4 Earnings Lag Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of -5.66% and 0.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Must-See Large Cap Earnings Charts

While technology stocks remain hot in 2021, there are other sectors that should be on your radar this earnings season.

Sheraz Mian headshot

Top Analyst Reports for Walmart, Intel & Cisco

Today's Research Daily features new research reports on 12 major stocks, including Walmart (WMT), Intel (INTC), and Cisco Systems (CSCO).

What's in Store for Edwards Lifesciences in (EW) Q4 Earnings?

Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q4 revenues.

Kevin Cook headshot

Bear of the Day: Penumbra (PEN)

Revolutionary catheter-based treatment for stroke events encounters device problems and a recall

Urmimala Biswas headshot

3 Best Buys from the Prospering Medical Instruments Industry

Despite the challenges posed by the COVID-19 pandemic, higher demand for lab-testing products, digital influence, and AI and robotics is likely to lend support to the Zacks Medical - Instruments industry. TMO, IDXX and STE are well positioned to gain.

Edwards Lifesciences (EW) Beats on Q3 Earnings, Margins Up

Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q3.

Edwards Lifesciences (EW) Q3 Earnings and Revenues Surpass Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 13.33% and 5.52%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Spectacular Earnings Charts

These popular stocks have some of the best earnings charts of the week.

The Zacks Analyst Blog Highlights: Edwards Lifesciences, QIAGEN, IDEXX, LHC and ResMed

The Zacks Analyst Blog Highlights: Edwards Lifesciences, QIAGEN, IDEXX, LHC and ResMed

3 MedTech Growth Stocks to Scoop Up Ahead of Q3 Earnings

Here are three growth stocks from the MedTech space that investors can pick ahead of the quarterly releases.

Earnings Preview: Edwards Lifesciences (EW) Q3 Earnings Expected to Decline

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Edwards Lifesciences' (EW) Q3 Earnings?

Robust customer adoption of the TruWave disposable pressure monitoring devices and the INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q3 revenues.

Edwards Lifesciences (EW) Up 1.8% Since Last Earnings Report: Can It Continue?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TMO vs. EW: Which Stock Is the Better Value Option?

TMO vs. EW: Which Stock Is the Better Value Option?

Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View

Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.

Kevin Cook headshot

Bear of the Day: Penumbra (PEN)

Growth stalls for an innovator in blood clot removal and the deadly shadow of stroke with catheter-based aspiration technologies

Edwards Lifesciences (EW) Q2 Earnings and Revenues Beat Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 126.67% and 18.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Earnings Season Could Be Great for Edwards Lifesciences (EW)

Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.